SR9009
Also known as: Stenabolic
SR9009 is a catalog-expanded sarm entry in ProtoComp's source-backed compound corpus. It is included for search, calculator math, stack awareness, and future research curation based on add sarm category and seed, expand compound catalog, explicit_target_list, local_seed, project_target. Published dosing, cycle length, and clinical-use claims are intentionally left null until compound-specific evidence is reviewed.
REV-ERB agonist (not a true SARM). Poor oral bioavailability — the compound sold to users as SR9009 likely has very limited systemic effect. Very short half-life.
Short-lived effects — cycle length based on anecdote rather than data.
Off-cycle: 4 weeks
Half-life ~4 hours. Requires frequent dosing for any sustained effect.
Contraindications
- • Pregnancy
Common side effects
- • Mild GI upset
Serious risks
- • Poor oral bioavailability makes benefit uncertain
- • Long-term safety unknown
Pregnancy / breastfeeding
Contraindicated
- Not a SARM — REV-ERB agonist
- Oral bioavailability is the fundamental problem — most user reports may be placebo
Sign in to calculate your dose, add this compound to your stack, and check for interactions with your current cabinet.